Zinzino Issues Shares to Settle Sanki and Bode Pro Acquisitions

Zinzino said it has issued 401,965 new B shares through a set-off of claims held by S&M Nano-Biotechnology S.A. de C.V. in connection with its acquisition of assets and subsidiaries of Mexico-based direct seller Sanki, announced in November 2025. The company also issued 69,621 B shares as payment related to its September 2025 acquisition of Bode Pro.

Under the Sanki agreement, the acquisition was completed on January 1, 2026, for a fixed price of 8 million dollars, 7 million dollars of it in Zinzino shares and 1 million dollars in cash, plus up to 12 million dollars in performance-based earn-outs payable in shares. The deal included Sanki's subsidiaries in Colombia and Peru.

Following the issues, Zinzino has 33,521,574 B shares and 38,634,966 shares in total outstanding, representing dilution of 1.22 percent. Zinzino launched its own operations in Peru in February and combined with It Works! in January.